Pages that link to "Q30463728"
Jump to navigation
Jump to search
The following pages link to Preventing pneumococcal bacteremia in patients at risk. Results of a matched case-control study (Q30463728):
Displaying 42 items.
- Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults (Q22242958) (← links)
- Vaccines for preventing pneumococcal infection in adults (Q24201474) (← links)
- Serotype-specific mortality from invasive Streptococcus pneumoniae disease revisited (Q24803495) (← links)
- Pneumococcal vaccines for preventing pneumonia in chronic obstructive pulmonary disease. (Q30238816) (← links)
- [Pneumococcal vaccine effectiveness in the elderly. Systematic review and meta-analysis]. (Q31113787) (← links)
- Invasive pneumococcal infections among persons with and without underlying medical conditions: implications for prevention strategies (Q33353828) (← links)
- Effectiveness of the 23-valent polysaccharide pneumococcal vaccine against invasive pneumococcal disease in people 60 years or older (Q33542866) (← links)
- The clinical effectiveness of pneumococcal vaccination: a brief review (Q33725096) (← links)
- Prevention of influenza and pneumococcal pneumonia in Canadian long-term care facilities: how are we doing? (Q33955782) (← links)
- The prevention of pneumococcal disease by vaccines: promises and challenges (Q34218669) (← links)
- Pneumococcal disease in the elderly: what is preventing vaccine efficacy? (Q34273624) (← links)
- Rethinking recommendations for use of pneumococcal vaccines in adults (Q34326459) (← links)
- Is the recommendation for pneumococcal vaccination of HIV patients evidence based? (Q34374684) (← links)
- The burden of invasive pneumococcal disease and the potential for reduction by immunisation (Q34535200) (← links)
- Effect of the conditional cash transfer program Oportunidades on vaccination coverage in older Mexican people (Q34802890) (← links)
- Pneumococcal Vaccination and Revaccination of Older Adults (Q34926870) (← links)
- Comparison of pneumococcal polysaccharide and CRM197-conjugated pneumococcal oligosaccharide vaccines in young and elderly adults. (Q35533941) (← links)
- The 23-valent pneumococcal polysaccharide vaccine. Part I. Efficacy of PPV in the elderly: a comparison of meta-analyses. (Q35793500) (← links)
- The effectiveness of pneumococcal polysaccharide vaccines in adults: a systematic review of observational studies and comparison with results from randomised controlled trials (Q35857208) (← links)
- Immune profile of asplenic patients following single or double vaccine administration: A longitudinal cross-sectional study (Q36160043) (← links)
- Streptococcus pneumoniae: description of the pathogen, disease epidemiology, treatment, and prevention (Q36257961) (← links)
- Effectiveness of 23-valent pneumococcal polysaccharide vaccination in preventing community-acquired pneumonia hospitalization and severe outcomes in the elderly in Spain (Q36277159) (← links)
- Effect of influenza and pneumococcal vaccines in elderly persons in years of low influenza activity (Q36665557) (← links)
- Additive preventive effect of influenza and pneumococcal vaccines in the elderly: results of a large cohort study (Q36887932) (← links)
- Effectiveness of pneumococcal polysaccharide vaccine for preschool-age children with chronic disease (Q37093763) (← links)
- Factors associated with pneumococcal polysaccharide vaccination of the elderly in Spain: A cross-sectional study (Q37135413) (← links)
- Vaccination of adults with 23-valent pneumococcal polysaccharide vaccine induces robust antibody responses against pneumococcal serotypes associated with serious clinical outcomes (Q37197138) (← links)
- Pneumococcal vaccination of elderly adults: new paradigms for protection. (Q37290048) (← links)
- Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults (Q37868241) (← links)
- Pneumococcal Vaccination in Adults (Q40428589) (← links)
- Pneumococcal vaccination in hospitalized elderly patients: role of the pharmacist (Q46161480) (← links)
- Pneumococcal immunizations at flu clinics: the impact of community-wide outreach (Q50679559) (← links)
- Cost-effectiveness analysis of pneumococcal vaccination for elderly individuals in The Netherlands. (Q53326961) (← links)
- Cost-effectiveness analysis of pneumococcal vaccination of adults and elderly persons in Belgium. (Q53333249) (← links)
- Invasive pneumococcal disease epidemiology and effectiveness of 23-valent pneumococcal polysaccharide vaccine in Alaska Native adults (Q58097284) (← links)
- Incremental effectiveness of pneumococcal vaccine on simultaneously administered influenza vaccine in preventing pneumonia and pneumococcal pneumonia among persons aged 65 years or older (Q60438782) (← links)
- Cost-effectiveness of pneumococcal vaccination for prevention of invasive pneumococcal disease in the elderly: an update for 10 Western European countries (Q60624546) (← links)
- Clinical effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumonia in middle-aged and older adults: A matched case–control study (Q63483462) (← links)
- A cost-effectiveness analysis of pneumococcal vaccination in street-involved, HIV-infected patients (Q73217865) (← links)
- Pneumococcal Pneumonia (Q73235119) (← links)
- Decreasing invasive pneumococcal disease in the elderly: a state-level analysis (Q83843923) (← links)
- Pneumococcal Disease and the Effectiveness of the PPV23 Vaccine in Adults: A Two-Stage Bayesian Meta-Analysis of Observational and RCT Reports (Q90428867) (← links)